Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2098030 | chr14:74421321 | C/T | 4.89E-7 | 176 | 25.28 | 28.38 | 7.4 | KM Plot |
PCPG | rs2106538 | chr22:21298315 | C/T | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs2109427 | chr12:6592082 | A/C | 0.000283 | 176 | 16.3 | 26.27 | 25.42 | KM Plot |
PCPG | rs2109752 | chr14:74629668 | T/G | 2.29E-5 | 175 | 25.4 | 26.92 | 10.43 | KM Plot |
PCPG | rs2128871 | chr15:30946169 | C/T | 0 | 177 | 25.87 | 23.43 | 3.17 | KM Plot |
PCPG | rs2128872 | chr15:30946160 | C/T | 1.11E-16 | 174 | 25.6 | 24.23 | 3.17 | KM Plot |
PCPG | rs2128968 | chr13:64106046 | A/C | 3.05E-5 | 177 | 22.63 | 21.55 | 26.57 | KM Plot |
PCPG | rs2137230 | chr2:107233134 | G/C | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs2138112 | chr3:80576523 | T/C | 6.94E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |
PCPG | rs2145319 | chr6:26496762 | G/C | 6.66E-7 | 177 | 10.68 | 35.32 | 24.5 | KM Plot |
PCPG | rs2147169 | chr13:37585665 | C/T | 0.000272 | 178 | 4.17 | 25 | 25.47 | KM Plot |
PCPG | rs2157466 | chr22:27382132 | C/G | 0.000209 | 175 | 25.4 | 24.98 | 24.3 | KM Plot |
PCPG | rs2166720 | chr2:61577435 | T/C | 0.000452 | 178 | 24.1 | 30.93 | 17.85 | KM Plot |
PCPG | rs2170420 | chr8:72072077 | C/T | 5.64E-6 | 178 | 10.3 | 22.63 | 25.92 | KM Plot |
PCPG | rs2170761 | chr15:30946306 | C/G | 0 | 178 | 25.77 | 23.43 | 3.17 | KM Plot |